Detalhe da pesquisa
1.
Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials.
Am J Nephrol
; 53(10): 701-710, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450264
2.
Development of a unified clinical trial database for Alzheimer's disease.
Alzheimers Dement
; 11(10): 1212-21, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25676387
3.
Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial.
Alzheimers Dement (N Y)
; 6(1): e12107, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33344752
4.
Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.
PLoS One
; 10(6): e0128313, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26039057
5.
Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.
Front Cell Neurosci
; 8: 203, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25126056
6.
Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain.
J Cereb Blood Flow Metab
; 29(6): 1084-98, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19319146